Back
Meta Platforms, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
49
META
Meta Platforms, Inc.
Last Price:
$664.87
Seasonality Move:
8.82%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
49
Meta Platforms, Inc. (META)
is a Sell
Is Meta Platforms, Inc. a Buy, Sell or Hold?
-
The current Meta Platforms, Inc. [META] share price is $664.94. The Score for META is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
META is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms, Inc.'s stock price today?
-
The Meta Platforms, Inc. share price today is $664.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
META Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 55.74 | Buy |
| Chaikin Money Flow: | 6165284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (616.99 - 666.17) | Buy |
| Bollinger Bands (100): | (647.03 - 764.01) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.24 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -246560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 33.24) | Buy |
| Bollinger Bands (100): | (10.76 - 24.28) | Buy |
META Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 656.01 | Buy |
| 20-day SMA: | 652.75 | Buy |
| 50-day SMA: | 659.31 | Buy |
| 200-day SMA: | 671.78 | Sell |
| 8-day EMA: | 658.37 | Buy |
| 20-day EMA: | 652.38 | Buy |
| 50-day EMA: | 662.81 | Buy |
| 200-day EMA: | 667.36 | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34 | Buy |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 22.08 | Buy |
| 200-day SMA: | 13.64 | Buy |
| 8-day EMA: | 33.98 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 23.99 | Buy |
| 200-day EMA: | 17.62 | Buy |
Meta Platforms, Inc. Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $5.09 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Meta Platforms, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||